NCT04573270View on ClinicalTrials.gov

Mesenchymal Stem Cells for the Treatment of COVID-19

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 24, 2020

Primary Completion Date

August 20, 2020

Study Completion Date

September 1, 2020

Conditions
Covid19Prophylaxis
Interventions
BIOLOGICAL

PrimePro

Intravenous Injection

OTHER

Placebo

Intravenous Injection

Trial Locations (1)

92032

Southern California Hospital at Culver City / Southern California Hospital at Hollywood, Culver City

All Listed Sponsors
collaborator

HeartStem Institute

UNKNOWN

lead

Thomas Advanced Medical LLC

INDUSTRY

NCT04573270 - Mesenchymal Stem Cells for the Treatment of COVID-19 | Biotech Hunter | Biotech Hunter